Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 12 % of short-term debt in 2025; threshold 65 %.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
Le Double Myosotis from Beauvechain, company number BE0442295056, closed financial year 2025 with a result of € 10,205 after tax. For that financial year Le Double Myosotis recorded a gross margin of € 59,787 and equity of € 246,497. Compared with financial year 2024, the result moved from € 3,300 to € 10,205. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 21, 2026.
€ 246,497
▲ 4% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 10,205
▲ 209% vs 2024
Profit after tax over the fiscal year.
€ 8,055
▼ 36% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € -174,375.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 292
▼ 96% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 12,903
▲ 26% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 49,593 | € 53,048 | € 52,809 | € 59,787 | ▲ 13% |
| Profit after taxes | € -250 | € 2,855 | € 3,300 | € 10,205 | ▲ 209% |
| Equity | € 230,136 | € 232,992 | € 236,292 | € 246,497 | ▲ 4% |
| Total debts | € 198,953 | € 160,590 | € 117,754 | € 65,102 | ▼ 45% |
| Cash | € 6,537 | € 10,114 | € 12,664 | € 8,055 | ▼ 36% |
| Land & buildings | € 419,553 | € 380,467 | € 341,382 | € 303,543 | ▼ 11% |
| Retained profit | € -190,735 | € -187,880 | € -184,580 | € -174,375 | ▲ € 10,205 |
| Bank debt | € 76,882 | € 52,380 | € 26,769 | € 0 | ▼ 100% |
| Balance sheet total | € 429,089 | € 393,582 | € 354,046 | € 311,598 | ▼ 12% |
Key figures of Le Double Myosotis, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Le Double Myosotis?
What happened at Le Double Myosotis in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 10,205 (▲ 209% vs 2024). Source: NBB ↗
- PHILIPPE THIBOU became a director. NBB
- PASCAL THIBOU became a director. NBB
- New establishment in Beauvechain. KBO
- Start of the company according to the CBE. KBO
In short
From € 250 loss in 2022 to € 10,205 profit in 2025.
Paid € 21,690 in corporate taxes since 2022.
Best year ever: 2025, with € 10,205 profit.
Management
Behind Le Double Myosotis are PHILIPPE THIBOU and PASCAL THIBOU.
Directors
According to the 2025 annual accounts
PHILIPPE THIBOU
Director
since 2024
PASCAL THIBOU
Director
since 2010
Establishments
Establishment units
Physical locations of this company
Rue du Petit Paradis,H.-M. 1
1320 Beauvechain
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 6 companies are registered at this address.
All companies at this address →La Fresnaye
€ 394,043 gross margin · 2025
EURO TAX CONSULTING
€ -81 gross margin · 2025
NAOR
€ -4,361 gross margin · 2025
LeBonBail
€ 2,920 gross margin · 2025
URBANECO
€ -13,193 gross margin · 2025
+1 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0442.295.056
- VAT number
- BE 0442.295.056
- Registered office
- Rue du Petit Paradis,H.-M. 1, 1320 Beauvechain
- Names & denominations
- Le Double Myosotis
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 22 October 1990
- Peppol
- Not registered